問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberSGN35-031
Active

2020-12-25 - 2025-07-31

Phase III

Terminated5

ICD-10C82.50

Diffuse follicle center lymphoma, unspecified site

ICD-10C82.59

Diffuse follicle center lymphoma, extranodal and solid organ sites

ICD-10C83.10

Mantle cell lymphoma, unspecified site

ICD-10C83.19

Mantle cell lymphoma, extranodal and solid organ sites

ICD-10C83.30

Diffuse large B-cell lymphoma, unspecified site

ICD-10C83.39

Diffuse large B-cell lymphoma, extranodal and solid organ sites

ICD-10C83.80

Other non-follicular lymphoma, unspecified site

ICD-10C83.89

Other non-follicular lymphoma, extranodal and solid organ sites

ICD-10C84.90

Mature T/NK-cell lymphomas, unspecified, unspecified site

ICD-10C84.99

Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites

ICD-10C84.A0

Cutaneous T-cell lymphoma, unspecified, unspecified site

ICD-10C84.A9

Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites

ICD-10C84.Z0

Other mature T/NK-cell lymphomas, unspecified site

ICD-10C84.Z9

Other mature T/NK-cell lymphomas, extranodal and solid organ sites

ICD-10C85.10

Unspecified B-cell lymphoma, unspecified site

ICD-10C85.19

Unspecified B-cell lymphoma, extranodal and solid organ sites

ICD-10C85.20

Mediastinal (thymic) large B-cell lymphoma, unspecified site

ICD-10C85.29

Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites

ICD-10C85.80

Other specified types of non-Hodgkin lymphoma, unspecified site

ICD-10C85.89

Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites

ICD-10C85.90

Non-Hodgkin lymphoma, unspecified, unspecified site

ICD-10C85.99

Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites

ICD-10C86.4

Blastic NK-cell lymphoma

ICD-10C88.4

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9202.80

Other lymphomas, unspecified, extranodal solid organ sites

  • Trial Applicant

    Pharmaceutical Research Associates Taiwan Inc.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/02/01

Investigators and Locations

Principal Investigator Tsai-Yun Chen Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Tai-Chung Huang Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 劉鴻霖 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hao-Yuan Wang Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hung Chang Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    30 participants

  • Global

    400 participants